| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |